BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 1, 2005
View Archived Issues
Topical treatment with the novel thiazolidinedione BP-1107 reduces epidermal hyperplasia
Read More
Patients with chronic primary insomnia improve after eszopiclone therapy
Read More
Ono updates latest pipeline developments
Read More
Antitumor activity and improved toxicity of new agent to target and suppress survivin
Read More
New SK inhibitors: candidates for hyperproliferative, inflammatory and angiogenic diseases
Read More
PEP-005 Topical produces statistically significant complete clearance of AK skin lesions in phase II
Read More
LY-156735 reduces body weight, without altering food consumption
Read More
Adherex Technologies gets IND clearance for eniluracil trials
Read More
BioDelivery Sciences International plans trials for BEMA Long Acting Analgesic
Read More
Y's advances YSPSL into phase II for prevention of delayed graft function
Read More
Enrollment completed in phase III study of CellCept for myasthenia gravis
Read More
Phase II maribavir study completes enrollment
Read More
One-year trial data show fewer liver function abnormalities with sitaxsentan
Read More
European filing for bifeprunox delayed until 2008
Read More
SuppreMol launched as new company
Read More
AAGP protects skin cells from ultra violet-C radiation
Read More
XACT trial of AMD-070 now enrolling HIV patients
Read More
Vitae begins phase II study for VTP-201227 in psoriasis
Read More
Phase II trial assesses VTP-195183 in combination with G-CSF
Read More
Acambis begins phase I trial for C. difficile vaccine
Read More
New orally active MetAP2 inhibitor with promising in vivo antitumor activity
Read More
BioInvent's antibody candidate for atherosclerosis
Read More
Paliperidone ER submitted for FDA approval in schizophrenia
Read More
Korean approval for udenafil in erectile dysfunction
Read More
Polyphenon E Ointment NDA accepted for review
Read More
Spectrum selective kinase inhibitors from Exelixis evaluated in phase I trials
Read More
Phase I results encourage further investigation of SNS-595
Read More
Pfizer patents disclose compounds with potential for HIV and AIDS
Read More
Recent patents describe novel agents for metabolic disorders
Read More